These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27416557)

  • 1. Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria.
    Vijayakumar S; Manogar P; Prabhu S
    Biomed Pharmacother; 2016 Oct; 83():362-371. PubMed ID: 27416557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.
    Chang CE; Ai R; Gutierrez M; Marsella MJ
    Methods Mol Biol; 2012; 819():595-613. PubMed ID: 22183560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effort to discover the preferred conformation of the potent AMG3 cannabinoid analog when reaching the active sites of the cannabinoid receptors.
    Durdagi S; Papadopoulos MG; Mavromoustakos T
    Eur J Med Chem; 2012 Jan; 47(1):44-51. PubMed ID: 22071252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids: potential targets for bladder dysfunction.
    Ruggieri MR
    Handb Exp Pharmacol; 2011; (202):425-51. PubMed ID: 21290238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in cannabinoid ligands.
    Padgett LW
    Life Sci; 2005 Aug; 77(14):1767-98. PubMed ID: 15993427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanobacteria: potential candidates for drug discovery.
    Dixit RB; Suseela MR
    Antonie Van Leeuwenhoek; 2013 May; 103(5):947-61. PubMed ID: 23532410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain cannabinoid systems as targets for the therapy of neurological disorders.
    Consroe P
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):534-51. PubMed ID: 9974182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptors in atherosclerosis.
    Steffens S; Mach F
    Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically labile cannabinoid esters: a 'soft drug' approach for the development of cannabinoid-based therapeutic drugs.
    Minutolo F; Cascio MG; Carboni I; Bisogno T; Prota G; Bertini S; Digiacomo M; Bifulco M; Di Marzo V; Macchia M
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4878-81. PubMed ID: 17604171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
    Onaivi ES
    Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).
    Myint KZ; Xie XQ
    Methods Mol Biol; 2015; 1260():149-64. PubMed ID: 25502380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid signaling in glioma cells.
    Ellert-Miklaszewska A; Ciechomska I; Kaminska B
    Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.